500674 Stock Overview
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Sanofi India Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹8,470.70 |
52 Week High | ₹9,370.35 |
52 Week Low | ₹5,329.70 |
Beta | 0.34 |
1 Month Change | 10.24% |
3 Month Change | 0.77% |
1 Year Change | 41.70% |
3 Year Change | 11.33% |
5 Year Change | 51.10% |
Change since IPO | 2,320.20% |
Recent News & Updates
Recent updates
Shareholder Returns
500674 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 0.3% | -2.5% | -2.5% |
1Y | 41.7% | 55.2% | 44.5% |
Return vs Industry: 500674 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 500674 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
500674 volatility | |
---|---|
500674 Average Weekly Movement | 3.5% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 500674 has not had significant price volatility in the past 3 months.
Volatility Over Time: 500674's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1956 | 2,651 | Rodolfo Hrosz | www.sanofiindialtd.com |
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, antihistamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products.
Sanofi India Limited Fundamentals Summary
500674 fundamental statistics | |
---|---|
Market cap | ₹195.09b |
Earnings (TTM) | ₹6.03b |
Revenue (TTM) | ₹28.51b |
32.4x
P/E Ratio6.8x
P/S RatioIs 500674 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
500674 income statement (TTM) | |
---|---|
Revenue | ₹28.51b |
Cost of Revenue | ₹12.01b |
Gross Profit | ₹16.50b |
Other Expenses | ₹10.47b |
Earnings | ₹6.03b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 261.78 |
Gross Margin | 57.88% |
Net Profit Margin | 21.15% |
Debt/Equity Ratio | 0% |
How did 500674 perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield64%
Payout RatioDoes 500674 pay a reliable dividends?
See 500674 dividend history and benchmarksSanofi India dividend dates | |
---|---|
Ex Dividend Date | May 03 2024 |
Dividend Pay Date | Jun 13 2024 |
Days until Ex dividend | 14 days |
Days until Dividend pay date | 55 days |
Does 500674 pay a reliable dividends?
See 500674 dividend history and benchmarks